Supply Of Inj. Insulin Degludec/insulin Aspart (r-dna Origin) Solution For Subcutaneous Injection. 1 Ml Of The Solution Contains 100 Units Insulin Degludec & Insulin Aspart (70% Soluble Insulin Degludec And 30% Soluble Insulin Aspart) Equivalent To 2.56 Mg Salt-free Anhydrous Insulin Degludec And 1.05 Mg Salt-free Anhydrous Insulin Aspart In 3 Ml Pre-filled Pen /flextouch. Note- Five Needle Suitable For Theuse Of The Every Five Pre Filled Pen ] This is a PAC tender. Bid closing date: 19-10-2026.

Detailed eligibility criteria are available in the tender document.
Download document →